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Abstract
PURPOSE: To validate a new low-dose and rapid stepwise individualized algorithm for non-invasive
assessment of ischemic coronary artery disease by sequential use of prospectively ECG-triggered
low-dose CT coronary angiography (CTCA) and low-dose single-photon emission computed
tomography myocardial perfusion imaging (SPECT-MPI). METHODS: Forty patients referred for
elective invasive coronary angiography (CA) were prospectively enrolled to undergo a comprehensive
non-invasive evaluation with low-dose CTCA and a dose-reduced stress/rest SPECT-MPI scan (using
dedicated reconstruction algorithms for low count scans). The following algorithm was reviewed:
CTCA first, followed by a stress-only MPI if a coronary stenosis (>/= 50% diameter narrowing) or
equivocal findings were observed. Only abnormal stress MPI scans were followed by rest MPI. The
accuracy of the individualized algorithm to predict coronary revascularization and its mean effective
radiation dose were assessed. RESULTS: CTCA documented CAD in 18 and equivocal findings in two
patients, thus, requiring additional stress MPI scans. Of these, 16 were abnormal, therefore requiring a
rest MPI scan, revealing ischemia in 15 patients. Sensitivity, specificity, negative and positive predictive
value, and accuracy of the individualized algorithm for predicting coronary revascularization was
93.3%, 96.0%, 96.0%, 93.3% and 95.0% on a per-patient base. The mean effective radiation dose was
significantly lower for the individualized (4.8 +/- 3.4 mSv) versus the comprehensive method (8.1 +/-
1.5 mSv) resulting in a total population radiation dose reduction of 132.6 mSv. CONCLUSION: This
new individualized low-dose algorithm allows rapid and accurate prediction of invasive CA findings
and of treatment decision with minimized radiation dose.
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Abstract 
Purpose To validate a new low-dose and rapid stepwise individualized algorithm for non-
invasive assessment of ischemic coronary artery disease by sequential use of prospectively 
ECG-triggered low-dose CT coronary angiography (CTCA) and low-dose single-photon 
emission computed tomography myocardial perfusion imaging (SPECT-MPI). 
Methods Forty patients referred for elective invasive coronary angiography (CA) were 
prospectively enrolled to undergo a comprehensive non-invasive evaluation with low-dose 
CTCA and a dose-reduced stress/rest SPECT-MPI scan (using dedicated reconstruction 
algorithms for low count scans). The following algorithm was reviewed: CTCA first, 
followed by a stress-only MPI if a coronary stenosis (≥ 50% diameter narrowing) or equivocal 
findings were observed. Only abnormal stress MPI scans were followed by rest MPI. The 
accuracy of the individualized algorithm to predict coronary revascularization and its mean 
effective radiation dose was assessed.  
Results CTCA documented CAD in 18 and equivocal findings in 2 patients, thus, requiring 
additional stress MPI scans. Of these, 16 were abnormal, therefore requiring a rest MPI scan, 
revealing ischemia in 15 patients. Sensitivity, specificity, negative and positive predictive 
value and accuracy of the individualized algorithm for predicting coronary revascularization 
was 93.3%, 96.0%, 96.0%, 93.3% and 95.0% on a per patient base. The mean effective 
radiation dose was significantly lower for the individualized (4.83.4 mSv) versus the 
comprehensive method (8.11.5 mSv) resulting in a total population radiation dose reduction 
of 132.6 mSv. 
Conclusion This new individualized low-dose algorithm allows rapid and accurate prediction 
of invasive CA findings and of treatment decision with minimized radiation dose. 
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Key Words: CT coronary angiography, prospective ECG-triggering, coronary artery disease, 
single-photon emission computed tomography 
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Introduction  
In western countries, coronary artery disease (CAD) is one of the major causes for morbidity 
and mortality. So far, invasive coronary angiography (CA) is the standard of reference for 
detection of CAD, although it is costly and associated with a non-negligible rate of procedural 
morbidity and mortality [1, 2]. Therefore, great efforts have been made to develop new non-
invasive approaches for imaging coronary atherosclerosis. A widely used and well established 
diagnostic tool for detecting ischemia is myocardial perfusion imaging (MPI) with single 
photon computed tomography (SPECT) [3]. However, it does not offer anatomic information 
for targeting revascularization. A recently introduced non-invasive imaging method is 
computed tomography coronary angiography (CTCA) [4], which permits visualisation of the 
coronary arteries and stenoses. Since 1999, when the first multislice spiral computed 
tomography was available [5], this method has been developed continuously [4]. CTCA has a 
high negative predictive value (NPV) but does not provide functional information on lesion 
severity as reflected by its modest positive predictive value (PPV) [6, 7] which has affected its 
role in the clinical management in daily routine. A combination of SPECT-MPI with CTCA 
has therefore been suggested, as it would overcome the shortcomings of each technique and 
allow comprehensive anatomical and functional CAD assessment. Although feasibility [8, 9] 
and the potential added clinical value of non-invasive imaging combining MPI with CTCA 
has been documented [10], the practicability is so far hampered due to a total radiation burden 
up to 41mSv [11] and long duration of the protocol.  
Hence, there is an ongoing debate about the necessity and the correct indication of the 
combination of these two non-invasive diagnostic methods. Recent developments including 
prospective ECG-triggering allowing low-dose CTCA [12, 13] and improved reconstruction 
algorithms allowing tracer dose reduction for SPECT-MPI [14] represent important 
contributions which may shift the balance from harms towards benefits.  
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Using latest technical refinements to ensure low effective radiation dose from CTCA 
(prospective triggering) and from SPECT-MPI (new reconstruction algorithm for low counts 
scanning) we aimed at evaluating the accuracy to assess CAD and the radiation dose of a 
sequential algorithm in which the result of each diagnostic step determined whether an 
additional test was necessary within the following sequence: CTCA, SPECT-MPI at stress, 
and SPECT-MPI at rest. 
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Materials and methods 
 
Study population 
 
Forty patients with low to intermediate pretest probability who were referred for elective 
invasive CA due to suspected CAD were prospectively enrolled to undergo a low-dose CTCA 
and a low-dose stress/rest SPECT-MPI scan on the same day. Exclusion criteria were: Known 
CAD, hypersensitivity to iodinated contrast material, renal insufficiency (creatinine levels > 
150 µmol/l), non-sinus rhythm, or haemodynamic instability. Patients and invasive 
cardiologists in the catheterization laboratory were unaware of the CTCA and stress/rest 
SPECT-MPI results. The study protocol was approved by the institutional review board (local 
ethics committee of the University Hospital Zurich) and written informed consent was 
obtained from each patient.  
 
Proposed algorithm 
 
After completing all non-invasive CTCA and stress/rest MPI scans in each patient we 
reviewed an individualized algorithm using the following optimized stepwise approach: First, 
CTCA findings were analyzed. Second, stress-only SPECT-MPI was added if at least one 
coronary stenosis (≥ 50% diameter narrowing) or equivocal findings were observed by 
CTCA. Third, rest MPI was included into the analysis if stress MPI revealed abnormal 
findings. Accuracy of this individualized algorithm to predict decisions of the interventional 
cardiologists with regard to perform percutaneous coronary intervention (PCI) in the 
catheterization laboratory based on CA and clinical information was assessed. These 
decisions served as standard of reference.  
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CTCA data acquisition and analysis 
 
CTCA scans were performed on a stand alone LightSpeed VCT XT scanner (GE Healthcare) 
using prospective ECG-triggering as recently established [12] and validated [15]. By choosing 
the smallest possible window at only one distinct end-diastolic phase of the RR-cycle (i.e. 
75%, with a padding of 0 ms) and by adapting of tube current and voltage to the body-mass 
index (BMI) [16] we ascertained the lowest achievable effective radiation dose delivery. If 
necessary, patients received intravenous metoprolol (5 to 20 mg) (Metoprolol, AstraZeneca, 
London, UK) to achieve a target heart rate <63 bpm. Any step artifact was categorized as non-
diagnostic. Two readers experienced in cardiac radiology blinded for the SPECT-MPI results 
assessed all coronary vessels for the presence of significant stenosis, defined as narrowing of 
the coronary luminal diameter ≥ 50 %.   
 
SPECT-MPI data acquisition and analysis 
 
Adenosine stress and tracer injection was performed while the patient was lying on the 
scanner. Adenosine stress/rest SPECT-MPI was acquired immediately (i.e. < 5 minutes) after 
tracer injection on a dual-head detector camera (Ventri, GE Healthcare, Milwaukee, USA) to 
shorten total protocol time, as recently established [17], without the standard 90 minutes delay 
between tracer application and SPECT-MPI acquisition. SPECT-MPI imaging period was 
approximately 15 minutes for stress and rest each. As previously validated [14], a new 
dedicated iterative algorithm (Evolution for Cardiac, GE Healthcare), allowing a 50% tracer 
reduction by compensating for low count imaging was used for image reconstruction on a 
Xeleris workstation (GE Healthcare). Accordingly, we used half of the recommended 
standard 99mTc-tetrofosmin activity adapted to the BMI for stress and rest (i.e. BMI <25 
kg/m
2
: stress 150 MBq, rest 450 MBq; BMI ≥ 25 kg/m2: stress 200 MBq, rest 600 MBq). An 
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unenhanced CT scan was used for soft tissue attenuation correction. Image analysis was 
performed using standard software according to clinical practice as previously reported [6, 7], 
blinded for the CTCA findings.  
 
Effective radiation dose 
 
Effective radiation dose for CTCA was estimated as dose-length product (DLP) times a 
conversion coefficient for the chest k. The commenly used conversion factor is k = 0.014  
mSv / mGy x cm [18]. However, we chose a higher factor, i.e. k = 0.017 mSv / mGy x cm 
[19] to account for the higher susceptibility of females to breast cancer as we include 17 
females in our study. Radiation dose for SPECT MPI was calculated as 99mTc tetrofosmin 
activity times 7.9 mSv/GBq as suggested by the International Commission on Radiological 
Protection (ICRP) [20]. For invasive CA (diagnostic part only) dose-area product (DAP) was 
multiplied with a conversion factor for chest (k = 0.22 mSv / mGy x cm) according to the 
National Radiological Protection Board tables [21]. Total and mean effective radiation dose 
of the individualized algorithm for all patients was compared to the radiation dose if all tests 
would have been applied to all patients.  
 
Invasive coronary angiography data acquisition and analysis 
 
Experienced interventional cardiologists performed invasive CA in the catheterization 
laboratory. A coronary stenosis was defined as a diameter reduction of ≥ 50 % by visual 
assessment. Decision towards percutaneous coronary intervention (PCI) was taken by the 
interventional cardiologists during CA. This decision was based on an integration of anatomic 
coronary lesion findings with the previously assessed clinical information which had 
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originally triggered the referral for invasive CA. The operators were blinded for the 
information obtained in the non-invasive part of the study (CTCA, SPECT-MPI). 
 
Statistical analysis 
 
Results from the individualized algorithm were compared to the decision taken by the 
interventional cardiologist towards coronary revascularization per patient and per vessel 
territory. Sensitivity, specificity, PPV, NPV and accuracy were calculated for the 
individualized algorithm to predict revascularization decision. P values of the difference 
between the two mean effective radiation doses were calculated using a Wilcoxon signed 
ranks test. P values of less than 0.05 were considered statistically significant. All P values are 
two-sided, and the 95% confidence intervals are presented. SPSS software (SPSS 15.0, SPSS 
Inc.) was used for statistical testing. 
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Results 
Each examination, i.e. CTCA, SPECT-MPI and invasive CA was successfully performed in 
all 40 patients. Baseline characteristics of all patients included in this study are given in Table 
1. 
 
Algorithm 
 
Fig. 1 displays the individualized rapid low-dose algorithm. Twenty patients had no 
significant stenosis in CTCA (including 9 with normal coronaries and 11 with non-obstructive 
coronary atherosclerosis) and therefore no further diagnostic test was needed. In 2 patients 
with equivocal findings a stress SPECT-MPI was added, which was normal and, therefore, no 
rest MPI deemed necessary. Similarly, stress SPECT-MPI was added in 18 patients with at 
least one stenosis (in total there were 56 lesions) in CTCA, revealing an abnormal finding in 
16 patients triggering the request for a rest SPECT-MPI. The latter documented total (n=9) or 
partial (n=6) reversibility of the defect in 15 patients, indicating ischemia. In one patient the 
resting scan documented a fixed defect, reflecting a scar. Sensitivity, specificity, NPV, PPV 
and accuracy of the individualized algorithm for predicting coronary revascularization was 
93.3%, 96.0%, 96.0%, 93.3% and 95.0% per patient and 90.0%, 95.0%, 97.9%, 78.3% and 
94.0% per vessel territory.  
 
Invasive coronary angiography 
 
Interventional cardiologists decided to perform a PCI in 21 coronary lesions of 15 patients.  
 
Effective radiation dose 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
11 
The mean effective radiation dose from the non-invasive imaging study was 8.1  1.5 mSv 
per patient if all 3 steps of the diagnostic algorithm were applied, adding up to 325.7 mSv 
total effective radiation dose applied to the entire study population (Fig. 2). By using the 
individualized algorithm the mean effective radiation dose was significantly lower (4.8  3.4 
mSv) as less than half of the patients needed all diagnostic steps. This reduced the total 
effective radiation dose deployed to the patient population by 132.6 mSv to 193.1 mSv 
(p<0.001). The mean effective radiation dose from CTCA, which would be performed in all 
40 patients, was 2.1  0.7 mSv (DLP 120.8  43.2 mGycm). Radiation from stress-only 
SPECT-MPI, which would be required in 20 patients, was 1.4  0.2 mSv resulting from 
99mTc-tetrofosmin activity (207.6  33.7 MBq) and 1.1  0.1 mSv from the unenhanced CT 
for attenuation correction (DLP 62.6  6.1 mGycm), adding up to 2.5  0.2 mSv. Rest 
SPECT-MPI, requested in 16 patients, resulted in a mean radiation dose of 3.9  0.5 mSv 
(557.2  74.7 MBq).  
Mean effective radiation dose from purely diagnostic invasive CA (8.7  4.2 mSv; DAP 39.5 
 19.1 mGycm2) was comparable to the unselective combination of CTCA with stress/rest 
SPECT-MPI, but significantly higher than the mean effective radiation obtained from the 
individualized algorithm (p<0.001).  
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Discussion 
Our results document that the proposed individualized rapid algorithm for assessing CAD in 
patients with low to intermediate pretest likelihood has an excellent ability to either rule out 
functionally relevant stenoses or to predict the necessity of revascularization procedure 
despite minimized radiation dose exposure. This is remarkable as both non-invasive 
components, i.e. CTCA and SPECT-MPI, were performed with latest techniques allowing for 
massive reduction in total effective radiation dose. Prospective ECG-triggering has allowed to 
substantially reduce radiation dose of CTCA from about 15 to 20 mSv down to 1 to 3 mSv at 
maintained image quality [12] and accuracy [15, 22]. The estimated radiation dose from 
CTCA in the present study (2.1  0.7 mSv) lies well within this previously reported range. 
Similarly, we have minimized radiation dose from SPECT-MPI by using a dedicated iterative 
reconstruction algorithm allowing to inject half of the standard isotope activity. Another 
strength of the present algorithm lies in the fact that following the stepwise approach has 
prevented many patients from undergoing the whole sequence of the non-invasive tests, 
which resulted in a further significant decrease in radiation burden of the entire study 
population.  
Several studies have documented the complementary information provided by the two non-
invasive diagnostic methods CTCA and SPECT MPI [6, 22, 23]. We suggest an algorithm 
starting with CTCA first. In our study, 50% of all patients could be excluded correctly after 
CTCA from further tests. This reflects the high NPV of 64-slice CTCA, which was 
demonstrated in earlier studies [6, 15]. The ability to rule out correctly CAD and therefore to 
appropriately avoid the need of additional diagnostic methods renders CTCA an excellent tool 
to start the diagnostic algorithm in patients with low to intermediate pretest probability. By 
contrast, an abnormal 64-slice CTCA is a poor predictor of functionally relevant coronary 
stenoses [6]. Patients with positive CTCA should undergo further evaluation for obstructive 
CAD to ensure the physiological relevance of the lesion. Consequently, CTCA is not 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
13 
recommended as first diagnostic step in patients with elevated probability of CAD or those 
with advanced age as the latter confers a higher prevalence of severe coronary calcifications 
which both severely impairs the NPV of CTCA. Thus, our findings would not necessarily 
hold true when extrapolated to other patient populations with higher disease prevalence for 
which the algorithm may need appropriate modifications.  
In the present study less than half of the patients needed all diagnostic steps, indicating that 
our algorithm was adequately used in the appropriate target population with low to 
intermediate pretest probability. As a consequence, total radiation dose to the study 
population was significantly reduced by about 50%, resulting in an average effective radiation 
dose of 4.8  3.4 mSv per patient. This represents a dose reduction in the range of a power of 
magnitude compared to earlier studies combining SPECT-MPI with CTCA reaching values of 
41 mSv [11]. This is likely to have a major clinical impact, as the balance of harms and 
benefits is clearly shifted to the favourable end and therefore such combined and accurate 
non-invasive assessment of CAD will gain importance. This is further elucidated by the fact 
that almost two thirds of all patients referred to invasive evaluation in Europe will end up with 
a purely diagnostic invasive CA [24]. The morbidity and mortality associated with the 
invasiveness of the diagnostic CA may be more and more perceived as unjustified in view of 
valuable non-invasive alternatives. This is particularly true as the radiation burden of the latter 
was for long time been regarded as prohibitively high, but has now been massively reduced. 
In fact, our results document that with latest technical refinements associated with appropriate 
and well selected individualized use the resulting dose is reasonably low, comparable to half 
of the radiation obtained from diagnostic invasive CA.  
We acknowledge following limitations: First, this is a single-center study with only a small 
population of 40 patients. Therefore, the results of this hypothesizing generating pilot study 
may require confirmation in larger studies. Second, the present results must be read with 
caution when generalized to patient populations with disease prevalence different from our 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
14 
population. In fact, in high prevalence populations the algorithm would need adjustments as 
ischemia assessment may preferably precede any structural assessment such as CTCA. 
Furthermore, sinus rhythm and heart rate control is required for prospective ECG-triggering 
[12], which explains why beta-blockers where administered frequently, although this was 
comparable to previous reports [12, 13]. Although some concerns have been raised on 
whether beta-blockade may reduce extent and severity of SPECT-MPI, a recent systematic 
study has ruled out any effect of beta-blocker treatment on accuracy of SPECT-MPI [25]. 
Finally, although an individualized algorithm may be favourable for the individual patient, 
this may not be ideal for aspects of practicability, as in a busy site image reporting may not be 
available fast enough to allow online decisions with regard to next step scanning. 
Furthermore, even if such continuous decision making would be available, it may be a 
challenge for many sites to implement such flexible schedule for reasons of scanner and 
radioligand availability.  
In conclusion, this study shows that despite minimized radiation dose the proposed low-dose 
stepwise rapid algorithm accurately predicts which decision with regard to revascularization 
would be taken in the catheterization laboratory. 
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Figure legends 
 
Fig. 1: 
Individualized low-dose algorithm showing decisions taken in the study population (CA 
invasive coronary angiography, CAD coronary artery disease, CTCA computed tomography 
coronary angiography, MPI myocardial perfusion imaging). 
Fig. 2: 
Comparison of mean and total effective radiation dose for the individualized 
versus the non-selective algorithm (CTCA computed tomography coronary angiography, MPI 
myocardial perfusion imaging, STOP no further test required). *p<0.001 


  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SD standard deviation, CvRF cardiovascular risk factors 
Table 1. Baseline Characteristics (n = 40) 
Mean age ± SD (years) 62 ± 8.3 
Male (n) 23  
Mean Body-mass index ± SD (kg/m2) 27.1 ± 5.1  
CvRF  
   Positive family history (%) 35 
   Smoking (%) 40 
   Diabetes (%) 13 
   Hypertension (%) 63 
   Dyslipidemia (%)  500050 
Typical chest pain 06 (15%) 
Atypical chest pain 18 (45%) 
Dyspnea 08 (20%) 
Table
